AbbVie (ABBV) Price to FCF (2012 - 2026)

AbbVie (ABBV) has reported Price to FCF for 15 consecutive years, with 142.8 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to FCF rose 112.69% year-over-year to 142.8 in Q2 2026; TTM through Jun 2026 was 24.42, a 35.83% increase from a year earlier, with the FY2025 full-year figure at 22.68, up 28.9% from the prior year.
• Price to FCF was 142.8 for Q2 2026 at AbbVie, up from 107.82 in the prior quarter.
• Over five years, Price to FCF peaked at 264.35 in Q1 2025 and troughed at 31.97 in Q3 2022.
• A 5-year average of 81.39 and a median of 64.37 in 2024 frame the typical range for Price to FCF.
• Across the five-year window, Price to FCF surged 285.4% in 2024 and slumped 59.22% in 2026, its largest moves.
• Over 5 years, Price to FCF stood at 39.63 in 2022, then jumped by 51.87% to 60.19 in 2023, then decreased by 22.87% to 46.43 in 2024, then jumped by 77.99% to 82.64 in 2025, then soared by 72.8% to 142.8 in 2026.
• The last three Price to FCF figures came in at 142.8 (Q2 2026), 107.82 (Q1 2026), and 82.64 (Q4 2025), per Business Quant data.